SMECTA

This brand name is authorized in Ecuador, Estonia, France, Hong Kong SAR China, Lithuania, Poland, Romania, Singapore, Tunisia.

Active ingredients

The drug SMECTA contains one active pharmaceutical ingredient (API):

1
UNII A585MN1H2L - MONTMORILLONITE
 

Diosmectite is a natural aluminomagnesium silicate clay with a lamellar, non-fibrous crystalline structure that gives it strong adsorbent properties. Diosmectite has demonstrated efficacy in the treatment of acute watery diarrhoea in children.

 
Read more about Diosmectite

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
A07BC05 Diosmectite A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07B Intestinal adsorbents → A07BC Other intestinal adsorbents
Discover more medicines within A07BC05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria 3021-MEE-0917
EE Ravimiamet 1028472, 1063640
FR Base de données publique des médicaments 64450063, 69584073
HK Department of Health Drug Office 34268
LT Valstybinė vaistų kontrolės tarnyba 1010356, 1010357, 1063704, 1063705, 1092607
PL Rejestru Produktów Leczniczych 100016564, 100061530, 100266321, 100268662, 100334620, 100343027, 100358945, 100426836, 100455849
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W66204002, W66204003
SG Health Sciences Authority 06338P
TN Direction de la Pharmacie et du Médicament 5720011

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.